IRIS
CUCINOTTA, Domenico Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.699
NA - Nord America 13.331
AS - Asia 7.191
SA - Sud America 2.765
AF - Africa 241
Continente sconosciuto - Info sul continente non disponibili 235
OC - Oceania 14
Totale 38.476
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.070
RU - Federazione Russa 7.204
SG - Singapore 3.029
BR - Brasile 2.383
CN - Cina 2.141
IE - Irlanda 1.866
SE - Svezia 1.565
DE - Germania 962
HK - Hong Kong 728
UA - Ucraina 709
IT - Italia 622
FR - Francia 587
FI - Finlandia 447
VN - Vietnam 422
GB - Regno Unito 358
IN - India 206
AR - Argentina 127
BD - Bangladesh 107
CA - Canada 104
PL - Polonia 83
TR - Turchia 83
MX - Messico 82
IQ - Iraq 72
EC - Ecuador 66
ZA - Sudafrica 65
BE - Belgio 52
AT - Austria 51
MA - Marocco 47
VE - Venezuela 47
ID - Indonesia 46
JP - Giappone 42
NL - Olanda 41
CO - Colombia 40
ES - Italia 36
UZ - Uzbekistan 36
PK - Pakistan 35
PY - Paraguay 31
CI - Costa d'Avorio 28
KE - Kenya 28
IR - Iran 26
UY - Uruguay 26
TN - Tunisia 22
CL - Cile 21
JM - Giamaica 21
JO - Giordania 20
AZ - Azerbaigian 19
PE - Perù 18
AE - Emirati Arabi Uniti 17
CZ - Repubblica Ceca 17
DZ - Algeria 16
SA - Arabia Saudita 16
IL - Israele 15
MY - Malesia 15
CH - Svizzera 14
NP - Nepal 14
EG - Egitto 13
LB - Libano 13
KR - Corea 12
HN - Honduras 11
PH - Filippine 11
GE - Georgia 10
LV - Lettonia 9
AL - Albania 8
AU - Australia 8
KZ - Kazakistan 8
DO - Repubblica Dominicana 7
GT - Guatemala 7
PS - Palestinian Territory 7
RO - Romania 7
SY - Repubblica araba siriana 7
LT - Lituania 6
PA - Panama 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
CR - Costa Rica 5
EE - Estonia 5
ET - Etiopia 5
EU - Europa 5
GR - Grecia 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
BG - Bulgaria 4
BO - Bolivia 4
HU - Ungheria 4
KG - Kirghizistan 4
LK - Sri Lanka 4
LU - Lussemburgo 4
NG - Nigeria 4
NI - Nicaragua 4
OM - Oman 4
PT - Portogallo 4
QA - Qatar 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BY - Bielorussia 3
DK - Danimarca 3
KH - Cambogia 3
KW - Kuwait 3
Totale 38.212
Salva come PNG Salva come JPEG
Città #
Moscow 2.180
Dublin 1.862
Singapore 1.614
Ashburn 1.588
Jacksonville 1.433
Dallas 1.297
Chandler 1.259
Nyköping 757
Hong Kong 723
Beijing 715
San Jose 554
Council Bluffs 465
Princeton 338
Cambridge 329
The Dalles 323
Lauterbourg 302
Dearborn 297
Los Angeles 281
Des Moines 269
Medford 255
Boardman 224
Munich 211
São Paulo 196
Ann Arbor 195
New York 174
Buffalo 157
Bremen 141
Ho Chi Minh City 133
Messina 132
Tianjin 104
Jinan 97
Hanoi 90
Woodbridge 89
San Mateo 86
Wilmington 85
Shenyang 84
Redondo Beach 81
Lancaster 77
Helsinki 75
Warsaw 75
Rio de Janeiro 74
Pune 63
Belo Horizonte 57
Santa Clara 57
Orem 56
Frankfurt am Main 55
Curitiba 51
Nanjing 51
Brussels 50
Guangzhou 47
Turku 47
Brooklyn 45
Columbus 42
Zhengzhou 41
Atlanta 40
Hebei 40
Houston 40
Tokyo 40
Vienna 39
Chennai 37
Chicago 37
Porto Alegre 36
Montreal 35
Ningbo 35
Rome 35
Tashkent 35
Hangzhou 33
Johannesburg 33
Boston 32
Brasília 32
San Francisco 31
Düsseldorf 30
Norwalk 30
Quito 30
Haikou 29
Abidjan 28
Salvador 28
Milan 27
Nairobi 26
Seattle 26
Denver 25
Shanghai 25
Baghdad 24
Campinas 24
Goiânia 24
Manchester 24
Taizhou 24
Da Nang 22
Montevideo 22
Nanchang 22
Nuremberg 22
Augusta 21
Guarulhos 21
Guayaquil 21
Phoenix 21
Shenzhen 21
Ankara 20
Manaus 20
Amsterdam 19
London 19
Totale 21.388
Salva come PNG Salva come JPEG
Nome #
Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ). 320
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 298
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 297
Anorectic activity of NG-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats. 275
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 257
A DECREASED BRAIN-STEM CONTENT OF GABA MEDIATES HYPERINSULINEMIA IN OBESE ZUCKER RATS 251
1ST-PHASE INSULIN-RESPONSE TO INTRAVENOUS GLUCOSE IN CYSTIC- FIBROSIS PATIENTS WITH DIFFERENT DEGREES OF GLUCOSE-TOLERANCE 235
Altered platelet magnesium and plasma and urinary soluble form of intercellular adhesion molecule I (sICAM-1) concentrations in insulin dependent diabetes mellitus (IDDM) patients with microalbuminuria. 232
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 218
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 215
Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients. 214
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 202
THIONAMIDES-RELATED VASCULITIS IN AUTOIMMUNE THYROID DISORDERS: REVIEW OF CURRENT LITERATURE AND CASE REPORTS 200
CORRELATION BETWEEN URINARY ACTIVITY OF N-ACETYL-B-D-GLUCOSAMINIDASE (NAG) AND ALBUMIN EXCRETION RATE IN TYPE II (NON INSULIN-DEPENDENT) DIABETICS SUBJECTS. 199
Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse 198
Livelli di TSH e parametri metabolici in soggetti eutiroidei con diabete di tipo 2 198
Age and metabolic control influence lens opacity in type I, insulin-dependent diabetic patients 196
High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes 196
Multiple osteoporotic fractures complicating Wolfram syndrome 193
Influence of peroxisome proliferator-activated receptor-γ exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome 190
EFFETTO DEL POLIMORFISMO CETP TAQ1B SUL PROFILO LIPIDICO E SULLE SOTTOPOLAZIONI HDL NELLE DONNE CON E SENZA DIABETE DI TIPO 2 188
Secrezione insulinica e tolleranza glucidica in dislipidemici e loro modificazioni dopo trattamento ipolipemizzante. 188
Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin. 188
ALFA-INTERFERON TREATMENT INDUCES INSULIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS 186
Cardiovascular effects of raloxifene hydrochloride 186
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 185
Anticorpi anti P-53 in pazienti con diabete mellito di tipo 1 183
Altered platetel magnesium and urinary soluble form of intercellular adhesion molecule concentrations in insulin dependent diabetes mellitus patients with microalbuminuria 182
Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study cohort 181
Autoantibodies against cytokeratin 19 in patients with type 1 diabetes mellitus 175
Very High Frequency of the Polymorphism for the Insulin Receptor Substrate 1 (IRS-1) at Codon 972 (Glycine972Arginine) in Southern Italian Women with Polycystic Ovary Syndrome. 174
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock 172
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 170
A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. 170
APOLIPOPROTEIN A1 GENE PROMOTER POLYMORPHISM AND CORONARY HEART-DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS 169
Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. 169
[Circadian variations of T3 and T4 in euthyroid subjects]. 169
Anti-p53 autoantibodies in patients with IDDM 165
[beta-Adrenergic blockade and circadian variations of IRI]. 165
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 165
SERUM ACTIVITY OF BETA- N-ACETYLGLUCOSAMINIDASE IN OBESE HYPERINSULINEMIC SUBJECTS. 163
[Behavior of alpha 2-macroglobulin and alpha 1-antitrypsin in mature diabetics]. 162
Age and metabolic control influence lens opacity in IDDM patients 161
[Blood cortisol changes due to insulin hypoglycemia and serum renin dynamics in the cold pressor test in normal and hypertensive subjects]. 161
[Calcium and endocrine pancreas secretion. II. Effects of an infusion of calcium on insulin and glucagon secretion induced by intravenous administration of glucose]. 161
Correlates of total homocysteine plasma concentration in type 2 diabetes 160
Calcio e secrezione endocrina pancreatica Nota III. Efffetti di una infusione di calcio sulla secrezione glucagonica da ipoglicemia insulinica. 160
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 160
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 159
Age and metabolic control influence lens opacity in IDDM patients. 158
[Circadian variations of immunoreactive insulin and beta-receptors blockade]. 158
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 157
[Behavior of some indices of fibrinolysis (fibrinogen, FDP, plasminogen) in mature diabetics]. 157
ADULT HEIGHT EXCEEDING TARGET HEIGHT IN A PATIENT WITH CONGENITAL PANHYPOPITUITARISM DIAGNOSED AFTER THE AGE OF 25 YEARS 156
SERUM URINARY ACTIVITIES OF b-N-ACETYLGLUCOSAMINIDASE AND b-GLUCURONIDASE IN DIABETIC PATIENTS. 156
Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients 156
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2. 155
[Behavior of plasma renin activity (PRA) after administration of a calcium antagonist]. 154
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 153
Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study 152
Angiogenesis in patients with bisphosphonate-associated osteonecrosis of the jaw. 152
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 151
[P.R.A. and cold pressor test following beta receptor block during arterial hypertensive syndromes]. 151
Differente impatto dei polimorfismi APOC3 SST1 e CETP TAQ1B sul profilo lipidico e lipoproteico nelle donne con e senza diabete di tipo 2 151
IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappa B and reduces the inflammatory response in myocardial ischaemia-reperfusion injury 150
Valutazione delle apoproteine A e B, delle lipoproteine e dei lipidi plasmatici durante trattamento con benzafribato in varie forme di iperlipoproteinemia. 150
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 150
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 150
Influence of high-normal serum TSH levels on major cardiovascular risk factors and Visceral Adiposity Index in euthyroid type 2 diabetic subjects. 148
Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study 147
Gender differences in diabetic kidney disease: Focus on hormonal, genetic and clinical factors 146
A multicenter study on the prevalence of diabetic neuropathy in Italy 145
[Hyperhomocysteinemia and cardiovascular risk in diabetes mellitus] 145
[Circadian variations in glycemia and IRI in normal subjects, young and adult diabetics and in obese subjects]. 145
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2 145
Alterazioni della funzione urodinamica nel diabete mellito di tipo 2 144
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 144
[Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese patients]. 144
[Hypertriglyceridemia, IRI and platelet aggregation]. 143
Glucose tolerance, insulin secretion and peripheral sensitivity in thalassaemia major 142
[Fibrinolysis and the cold pressor test]. 142
[Circadian variations in blood cortisol and the rapid inhibition test with dexamethasone in primary and secondary hypertension patients]. 142
[Insulin secretion and beta-adrenergic blockade in normal subjects, obese subjects and obese diabetics after carbohydrate stimulation]. 142
[Thyroid hormones and adrenergic stimulation. II. TSH and reverse T3 behavior]. 141
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 141
HDL subclasses and the common CETP TaqIB variant predict the incidence of microangiopatic complications in type 2 diabetic women: A 9 years follow-up study 141
[Behavior of plasma renin activity (PRA) after administration of DOCA in normal subjects]. 140
Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury 138
Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus 138
beta-Adrenergic blockade and circadian variations of IRI 138
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 138
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 138
Glucose tolerance,insulin secretion and peripheral sensitivity in thalassemia major 137
EFFETTO DEL DIABETE E DELLA MENOPAUSA SUL PROFILO LIPIDICO E LA DISTRIBUZIONE DELLE SOTTOPOPOLAZIONI HDL NELLE DONNE 137
APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-I/C-III GENETIC POLYMORPHISMS AND CORONARY HEART-DISEASE IN DIABETES-MELLITUS 137
Livelli di TSH e parametri metabolici in soggetti diabetici di tipo 2 eutiroidei 137
[Calcium and endocrine pancreas secretion. I. Effects of an infusion of calcium on plasma levels of insulin and glucagon]. 137
Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients. 137
Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” 137
Factors affecting diabetes mellitus onset in cystic fibrosis: Evidence from a 10-year follow-up study 136
Totale 16.990
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.982
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.982
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.084 0 267 30 84 52 7 148 87 44 447 264 654
2022/20235.338 427 360 216 398 521 519 37 339 2.280 32 163 46
2023/20241.238 88 218 90 115 93 301 20 68 18 34 12 181
2024/20255.869 72 49 102 318 286 167 129 1.387 1.594 324 491 950
2025/202616.694 757 1.150 1.369 1.289 1.323 3.838 1.964 1.968 1.969 563 252 252
2026/20271.114 264 850 0 0 0 0 0 0 0 0 0 0
Totale 38.476